BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28973432)

  • 1. Staged Stereotactic Radiosurgery for Large Brain Metastases: Local Control and Clinical Outcomes of a One-Two Punch Technique.
    Dohm A; McTyre ER; Okoukoni C; Henson A; Cramer CK; LeCompte MC; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Watabe K; Laxton AW; Tatter SB; Chan MD
    Neurosurgery; 2018 Jul; 83(1):114-121. PubMed ID: 28973432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
    Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
    J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
    McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
    J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical resection and postoperative radiosurgery versus staged radiosurgery for large brain metastases.
    Dohm AE; Hughes R; Wheless W; Lecompte M; Lanier C; Ruiz J; Watabe K; Xing F; Su J; Cramer C; Laxton A; Tatter S; Chan MD
    J Neurooncol; 2018 Dec; 140(3):749-756. PubMed ID: 30367382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
    Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
    J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic radiosurgery for patients with multiple brain metastases: a case-matched study comparing treatment results for patients with 2-9 versus 10 or more tumors.
    Yamamoto M; Kawabe T; Sato Y; Higuchi Y; Nariai T; Watanabe S; Kasuya H
    J Neurosurg; 2014 Dec; 121 Suppl():16-25. PubMed ID: 25434933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastases.
    Jhaveri J; Chowdhary M; Zhang X; Press RH; Switchenko JM; Ferris MJ; Morgan TM; Roper J; Dhabaan A; Elder E; Eaton BR; Olson JJ; Curran WJ; Shu HG; Crocker IR; Patel KR
    J Neurosurg; 2018 Apr; 130(3):797-803. PubMed ID: 29676690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
    Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
    J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Outcomes of Upfront Stereotactic Radiosurgery Alone for Patients With 5 to 15 Brain Metastases.
    Hughes RT; McTyre ER; LeCompte M; Cramer CK; Munley MT; Laxton AW; Tatter SB; Ruiz J; Pasche B; Watabe K; Chan MD
    Neurosurgery; 2019 Aug; 85(2):257-263. PubMed ID: 29982831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic radiosurgery with concurrent lapatinib is associated with improved local control for HER2-positive breast cancer brain metastases.
    Parsai S; Miller JA; Juloori A; Chao ST; Kotecha R; Mohammadi AM; Ahluwalia MS; Murphy ES; Barnett GH; Vogelbaum MA; Angelov L; Peereboom DM; Suh JH
    J Neurosurg; 2019 Feb; 132(2):503-511. PubMed ID: 30738402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Gamma Knife Radiosurgery in Small Cell Lung Cancer: A Multi-Institutional Retrospective Study of the International Radiosurgery Research Foundation (IRRF).
    Cifarelli CP; Vargo JA; Fang W; Liscak R; Guseynova K; Warnick RE; Lee CC; Yang HC; Borghei-Razavi H; Maiti T; Siddiqui ZA; Yuan JC; Grills IS; Mathieu D; Touchette CJ; Cordeiro D; Chiang V; Hess J; Tien CJ; Faramand A; Kano H; Barnett GH; Sheehan JP; Lunsford LD
    Neurosurgery; 2020 Sep; 87(4):664-671. PubMed ID: 31599324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
    Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
    J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeat Stereotactic Radiosurgery for Locally Recurrent Brain Metastases.
    Koffer P; Chan J; Rava P; Gorovets D; Ebner D; Savir G; Kinsella T; Cielo D; Hepel JT
    World Neurosurg; 2017 Aug; 104():589-593. PubMed ID: 28450235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local tumor response and survival outcomes after combined stereotactic radiosurgery and immunotherapy in non-small cell lung cancer with brain metastases.
    Singh C; Qian JM; Yu JB; Chiang VL
    J Neurosurg; 2019 Feb; 132(2):512-517. PubMed ID: 30771783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-Fraction Radiosurgery Using Conservative Doses for Brain Metastases: Durable Responses in Select Primaries With Limited Toxicity.
    Cummings M; Youn P; Bergsma DP; Usuki KY; Walter K; Sharma M; Okunieff P; Schell MC; Milano MT
    Neurosurgery; 2018 Sep; 83(3):437-444. PubMed ID: 28945885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases.
    Varlotto JM; Flickinger JC; Niranjan A; Bhatnagar A; Kondziolka D; Lunsford LD
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1125-32. PubMed ID: 15990018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy.
    Sanghvi SM; Lischalk JW; Cai L; Collins S; Nair M; Collins B; Unger K
    Radiat Oncol; 2017 Feb; 12(1):43. PubMed ID: 28245881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton Stereotactic Radiosurgery for Brain Metastases: A Single-Institution Analysis of 370 Patients.
    Atkins KM; Pashtan IM; Bussière MR; Kang KH; Niemierko A; Daly JE; Botticello TM; Hurd MC; Chapman PH; Oh K; Loeffler JS; Shih HA
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):820-829. PubMed ID: 29976494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of conformity index and gradient index in patients undergoing stereotactic radiosurgery for a single metastatic tumor.
    Aiyama H; Yamamoto M; Kawabe T; Watanabe S; Koiso T; Sato Y; Higuchi Y; Ishikawa E; Yamamoto T; Matsumura A; Kasuya H
    J Neurosurg; 2018 Dec; 129(Suppl1):103-110. PubMed ID: 30544326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.